QEL-001 / Quell Therap 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
QEL-001 / Quell Therap
2021-001379-18: Phase I/II study of QEL-001 in A2-mismatch liver transplant patients Estudio de fase I/II del QEL-001 en pacientes de trasplante de hígado con disparidad de A2

Not yet recruiting
1/2
42
Europe
QEL-001, QEL-001, Suspension for injection
Quell Therapeutics Limited, Quell Therapeutics Limited
Prevention of liver transplant rejection Prevención de rechazo tras trasplante de hígado, Prevention of liver transplant rejection Prevención de rechazo tras trasplante de hígado, Body processes [G] - Immune system processes [G12]
 
 
LIBERATE, NCT05234190 / 2021-001379-18: Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients

Recruiting
1/2
33
Europe
QEL-001, HLA-A2 CAR-Treg
Quell Therapeutics Limited, Quell Therapeutics Limited
Rejection; Transplant, Liver, Liver Failure, Liver Diseases
09/25
03/40
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
QEL-001 / Quell Therap
2021-001379-18: Phase I/II study of QEL-001 in A2-mismatch liver transplant patients Estudio de fase I/II del QEL-001 en pacientes de trasplante de hígado con disparidad de A2

Not yet recruiting
1/2
42
Europe
QEL-001, QEL-001, Suspension for injection
Quell Therapeutics Limited, Quell Therapeutics Limited
Prevention of liver transplant rejection Prevención de rechazo tras trasplante de hígado, Prevention of liver transplant rejection Prevención de rechazo tras trasplante de hígado, Body processes [G] - Immune system processes [G12]
 
 
LIBERATE, NCT05234190 / 2021-001379-18: Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients

Recruiting
1/2
33
Europe
QEL-001, HLA-A2 CAR-Treg
Quell Therapeutics Limited, Quell Therapeutics Limited
Rejection; Transplant, Liver, Liver Failure, Liver Diseases
09/25
03/40

Download Options